Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rabies01:28

Rabies

Rabies is a lethal zoonotic disease caused by a single-stranded, negative-sense RNA virus of the Lyssavirus genus, within the family Rhabdoviridae. Its primary mode of transmission to humans is through bites or saliva-contaminated scratches from infected mammals such as dogs, bats, raccoons, or foxes. Transmission can also occur if infectious saliva contacts abraded skin or intact mucous membranes, including the conjunctiva.Viral Entry and Early ReplicationOnce introduced at the bite or scratch...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Arboviral Encephalitis01:25

Arboviral Encephalitis

Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fluid Therapy in the Critically Ill Patient.

The Veterinary clinics of North America. Small animal practice·2025
Same author

Bioavailability of Oral Ondansetron in Dogs: A Crossover Study.

Journal of veterinary pharmacology and therapeutics·2025
Same author

Validation of Wireless Harness for Measuring Respiratory Rate, Heart Rate, and Body Temperature in Hospitalized Dogs.

Veterinary sciences·2025
Same author

Assessment of microcirculation variables and endothelial glycocalyx using sidestream dark field videomicroscopy in anesthetized dogs undergoing cardiopulmonary bypass.

Frontiers in veterinary science·2023
Same journal

Practical Steps Toward Antimicrobial Stewardship for the General Practitioner.

The Veterinary clinics of North America. Small animal practice·2026
Same journal

Using Evidence-Based Veterinary Medicine and Artificial Intelligence to Support Clinical Decision Making in Veterinary Practice.

The Veterinary clinics of North America. Small animal practice·2026
Same journal

Feline Asthma-Update on Diagnosis and Treatment Recommendations.

The Veterinary clinics of North America. Small animal practice·2026
Same journal

Disease Prediction and Precision Veterinary Medicine: Applications, Opportunities, and Limitations of Artificial Intelligence in Small Animal Practice.

The Veterinary clinics of North America. Small animal practice·2026
Same journal

The Moving Target of Companion Animal Infectious Diseases: Emerging Threats and Evolving Solutions.

The Veterinary clinics of North America. Small animal practice·2026
Same journal

Challenging Gram-negative Infections: Perspectives from a Clinician and a Microbiologist.

The Veterinary clinics of North America. Small animal practice·2026
See all related articles

Related Experiment Video

Updated: May 29, 2026

Production and Purification of Non Replicative Canine Adenovirus Type 2 Derived Vectors
14:55

Production and Purification of Non Replicative Canine Adenovirus Type 2 Derived Vectors

Published on: December 3, 2013

Update on Canine Parvovirus.

Kristin Zersen1

  • 1Department of Clinical Sciences, Colorado State University, 300 W Drake Road, Fort Collins, CO 80523, USA.

The Veterinary Clinics of North America. Small Animal Practice
|May 27, 2026
PubMed
Summary
This summary is machine-generated.

Canine parvovirus (CPV) is a highly contagious dog disease. Vaccination is key for prevention, while supportive care like fluids and nutrition significantly improves survival rates, often exceeding 90% with treatment.

Keywords:
EnteritisOutpatient therapyParvovirusTreatment

More Related Videos

High-throughput Detection of Respiratory Pathogens in Animal Specimens by Nanoscale PCR
11:00

High-throughput Detection of Respiratory Pathogens in Animal Specimens by Nanoscale PCR

Published on: November 28, 2016

Related Experiment Videos

Last Updated: May 29, 2026

Production and Purification of Non Replicative Canine Adenovirus Type 2 Derived Vectors
14:55

Production and Purification of Non Replicative Canine Adenovirus Type 2 Derived Vectors

Published on: December 3, 2013

High-throughput Detection of Respiratory Pathogens in Animal Specimens by Nanoscale PCR
11:00

High-throughput Detection of Respiratory Pathogens in Animal Specimens by Nanoscale PCR

Published on: November 28, 2016

Area of Science:

  • Veterinary Medicine
  • Infectious Diseases
  • Canine Health

Background:

  • Canine parvovirus (CPV) is a prevalent and highly contagious infectious disease affecting dogs.
  • Transmission occurs primarily through the fecal-oral route, posing a significant risk in unvaccinated populations.
  • CPV infection can lead to severe gastrointestinal illness and has a high mortality rate without prompt intervention.

Purpose of the Study:

  • To summarize the key aspects of canine parvovirus, including prevention, transmission, and treatment.
  • To highlight the critical role of vaccination in CPV prevention strategies.
  • To outline the essential components of supportive care for CPV-infected dogs.

Main Methods:

  • This summary is based on established veterinary knowledge regarding canine parvovirus.
  • Information synthesized from clinical guidelines and epidemiological data on CPV.
  • Focus on core treatment modalities and prognostic factors.

Main Results:

  • Vaccination remains the most effective strategy for preventing canine parvovirus.
  • Intravenous fluids and enteral nutrition are crucial for managing CPV.
  • Supportive care, including antibiotics, gastrointestinal medications, and analgesics, is vital.
  • Treatment outcomes and prognosis are directly correlated with disease severity and complication development.

Conclusions:

  • Prompt and comprehensive supportive care can dramatically improve survival rates for canine parvovirus, potentially exceeding 90%.
  • Effective prevention through vaccination is paramount to reducing the incidence of CPV.
  • Understanding transmission routes and treatment protocols is essential for veterinary professionals and dog owners.